Copyright
©The Author(s) 2021.
World J Clin Oncol. Apr 24, 2021; 12(4): 195-216
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.195
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.195
Organ | Constraints | ||
Spinal cord | Dmax < 45 Gy | ||
Dmax < 40 Gy if 3 Gy/fraction | |||
Lung (total lung minus GTV; solely total lung for postoperative cases without GTV) | Mean dose < 20 Gy | ||
Mean dose < 8 Gy if post-pneumonectomy | |||
RT alone | RT with chemotherapy | Neoadjuvant treatment before surgery | |
V20 ≤ 40% | V20 ≤ 35% | V20 ≤ 30% | |
V10 ≤ 45% | V10 ≤ 40% | ||
V5 ≤ 65% | V5 ≤ 55% | ||
V20 < 10% and V5 < 60% if post-pneumonectomy | |||
Heart | Mean dose < 26 Gy | ||
V30 ≤ 45% | |||
Esophagus | Mean dose < 34 Gy | ||
Dmax ≤ 80 Gy | |||
V70 < 20% | |||
V50 < 50% | |||
Kidney | 20 Gy < 32% bilateral kidney | ||
Liver | Mean dose < 30 Gy | ||
V30 ≤ 40% |
- Citation: Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216
- URL: https://www.wjgnet.com/2218-4333/full/v12/i4/195.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i4.195